Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions

Real-World Use of Loteprednol Etabonate 0.5%/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions

James E Deom,1,2 Shane Kannarr,3 Patrick Vollmer4,5 1The Dry Eye Center of Northeastern Pennsylvania, Hazleton, PA, USA; 2Hazleton and Stroudsburg Eye Specialists, Hazle Township, PA, USA; 3Kannarr Eye Care, LLC, Pittsburg, KS, USA; 4Vita Eye Clinic, Shelby, NC, USA; 5Synvenio Group, Shelby, NC, USA...

Full description

Bibliographic Details
Main Authors: Deom JE, Kannarr S, Vollmer P
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:Clinical Ophthalmology
Subjects:
corticosteroid
ocular
retrospective
intraocular pressure
blepharokeratoconjunctivitis
real-world
Online Access:https://www.dovepress.com/real-world-use-of-loteprednol-etabonate-05tobramycin-03-ophthalmic-sus-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/real-world-use-of-loteprednol-etabonate-05tobramycin-03-ophthalmic-sus-peer-reviewed-fulltext-article-OPTH

Similar Items